Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R01 Clinical Trial Not Allowed)RFA-NS-22-034

Discovery of targets in the peripheral nervous system, central nervous system, immune system or other tissues in the body that can be used to develop treatments that have minimal side effects and little to no abuse/addiction liability 

Upcoming Receipt Date: October 4, 2022

Program Contact: Michael L. Oshinsky, PhD 

Email: [email protected]